Kumar Gunjan, Jena Samikshya, Snigdha Niher Tabassum, Basha Sakeenabi, Narayanan Jayaraj Kodangattil, Luke Alexander Maniangat
Department of Public Health Dentistry, Kalinga Institute of Dental Sciences, KIIT Deemed to Be University, Patia, Bhubaneswar 751024, Odisha, India.
Paediatric Dentistry Unit, School of Dental Sciences, Universiti Sains Malaysia, Health Campus, Kota Bharu 16150, Kelantan, Malaysia.
Vaccines (Basel). 2023 May 9;11(5):964. doi: 10.3390/vaccines11050964.
This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesitation/vaccine acceptance using a survey/questionnaire were included. After extensive research, 524 records were found, and after screening on the basis of eligibility criteria, only 23 papers were added to this review. Increased vaccine assumption percentage (>70%) among the population was found in two surveys nationwide (92.8%) and in Delhi (79.5%). For pooled estimates of COVID-19 vaccine acceptance and heterogeneity, twenty-three studies (23) consisting of 39,567 individuals reported for acceptance of COVID 19 vaccine in India.. Out of these, 26,028 individuals accepted the COVID-19 vaccine, giving a pooled estimate of 62.6% (95% CI: 55.6-69.4) with considerable heterogeneity (χ = 3397.3, < 0.0001; I = 99.40%). The results of this study give a brief insight into the percentage acceptance and hesitancy among the Indian population regarding COVID-19 vaccine immunisation. Future research and vaccine education initiatives can be steered by the findings of this work as a starting point.
本系统评价和荟萃分析旨在评估印度各邦对新冠疫苗的接受程度。纳入了发表在PubMed/Scopus/Cochrane/DOAJ/科学网上、聚焦于通过调查/问卷评估新冠疫苗犹豫/疫苗接受情况的文章。经过广泛研究,共找到524条记录,根据纳入标准筛选后,仅有23篇论文被纳入本评价。在全国范围内的两项调查(92.8%)以及德里(79.5%)的调查中,发现人群中疫苗接受率有所提高(>70%)。对于新冠疫苗接受情况的合并估计和异质性,23项研究(共39567人)报告了印度新冠疫苗的接受情况。其中,26028人接受了新冠疫苗,合并估计接受率为62.6%(95%置信区间:55.6 - 69.4),存在相当大的异质性(χ = 3397.3,< 0.0001;I² = 99.40%)。本研究结果简要揭示了印度人群对新冠疫苗免疫接种的接受率和犹豫情况。未来的研究和疫苗教育倡议可以以本研究结果为起点来开展。